Watson Pharmaceuticals, Inc.
   
To register click here

Watson Stock Price WPI

Company Description : The Company is engaged in the development, manufacture, marketing, sale and distribution of brand and generic pharmaceutical products. url: www.watsonpharm.com

Name:
Watson Pharmaceuticals, Inc.
Symbol:
NYSE:WPI
Stock Market:
New York Stock Exchange
Type:
Equity
ISIN:
Description:
 Change (p)Change (%)CurBidAskHighLowOpenVolumeTimeA
2.019.4723.2423.2421.4321.43123146220:00:00
stock Prices on this screen are 15 minutes delayed
To register Click hereRegister for free Watson Pharmaceuticals stock prices.

UPDATE: WATSON GETS US FDA OK FOR RAPAFLO(TM) (SILODOSIN) : NEW YORK (Thomson Financial) - UPDATE: WATSON RECEIVES US FDA APPROVAL FOR RAPAFLO(TM) (SILODOSIN) FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH) Chuck Mikolajczak cm COPYRIGHT Copyright Thomson Financial...

Free Watson Stock Charts

Watson Historical Stock Chart
Watson Pharmaceuticals Historical Stock Chart
Watson Monthly Stock Chart
Watson Pharmaceuticals Monthly Stock Chart
Watson Intraday stock chart
Watson Pharmaceuticals Intraday stock chart

To register Click hereRegister for FREE streaming stock charts featuring overlays, annotations and more than 80 different studies including Level 2 Scope and Average True Range.

FREE Company Reports (WPI) Free Annual Report - Click Here!

Get the Latest Watson Pharmaceuticals stock Price, quotes, trades and FREE Watson Pharmaceuticals stock charts, company information, annual reports, market news and announcements from ADVFN. We offer Intraday and historical stock prices for Watson Pharmaceuticals (WPI) and other New York Stock Exchange listed companies as well as company financials, Level 2 Data and the latest investor information from our stock market Message Boards.

Watson News

Latest Watson News Headlines
DateTimeSource
Headline
10/09/20088:47AMTFNFUPDATE: WATSON GETS US FDA OK FOR RAPAFLO(TM) (SILODOSIN)
10/09/20088:30AMPRNUSUPDATE: Watson Receives US FDA Approval for RAPAFLO(TM) (silodosin) for the Treatment of Benign Prostatic Hyperplasia (BPH)
10/09/20081:14AMTFNFUPDATE 1-FDA approves Watson urology drug Rapaflo
10/08/20086:00PMPRNUSWatson Receives US FDA Approval for RAPAFLO(TM) (silodosin) for the Treatment of Benign Prostatic Hyperplasia (BPH)
10/08/20088:30AMPRNUSWatson Announces Positive Data for Its Investigational Oxybutynin Topical Gel for the Treatment of Overactive Bladder at SUNA's
10/02/20081:49AMTFNFBRIEF-Watson notified of Oxytrol patent challenge
10/01/20085:03PMPRNUSWatson Notified of OXYTROL(R) Patent Challenge
09/29/20088:30AMPRNUSWatson Announces Positive Data for RAPAFLO(TM)(silodosin), Its Investigational Product for BPH, at Regional AUA Conferences
08/13/20089:46PMPRNUSWatson Announces District Court Ruling in Naproxen Sodium Patent Suit
08/06/20087:00AMPRNUSWatson Pharmaceuticals Reports Second Quarter 2008 Results
08/05/20088:00AMPRNUSUrologists Should Recognize the Cardiac Safety of Prescribed Medications, Article Concludes
08/05/20083:17AMTFNFBayer sues Novartis unit over generic contraceptive

Watson Company Information

 Sector  Turnover (m)  Profit (m)  EPS - Basic  PE ratio  Mkt Cap (m)  NMS 
  0.00 0.00   0.0 N/A
To register Click hereRegister for FREE access to the latest Watson Pharmaceuticals company information and fundamental data for other USA Equity companies. More than 100 separate statistics including accounts payable / sales and inventory / sales.

Latest Watson Stock Trade

 Type  Size  Price  Date  Tr.Time  Units 
  6842 23.24 10/13/2008 4:29PM USD


 



PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
40 site:2us nyse wpi081014 04:51 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )